Back to search

National and Kapodistrian University of Athens

Ανάπτυξη ζωικών προτύπων ανθρώπινων ασθενειών μέσω ιστο-ειδικής μειορρύθμισης γονιδίων ελέγχου ενδοκυτταρικών σηματοδοτικών δικτύων στο δίπτερο έντομο Drosophila melanogaster

Abstract

dc:description

The mechanisms that control “organismal” growth and its coordination with the availability of nutrients, in the cellular micro-environments, were unknown until a few decades ago. It is now widely accepted that the “mechanistic target of rapamycin” mTOR functions as a major nutrient sensor and a fundamental regulator of animal growth, and plays a central role in physiology, metabolism, aging, and disease. Its dysregulation has been strongly associated with several human disorders, including diabetes, neurodegenerative diseases, and cancer. mTOR is an evolutionary conserved serine/threonine protein kinase and is the catalytic core of two large multi-protein complexes named mTORC1 (mTOR complex 1) and mTORC2 (mTOR complex 2). Their function, substrate specificity, upstream inputs, downstream outputs, and sensitivity to rapamycin differ notably due to the distinct composition of their accessory proteins. mTORC1 is better characterized and reviewed out of the two mTOR complexes. It controls cell growth and metabolism by regulating anabolic and catabolic processes, including protein, lipid, and nucleotide synthesis. mTORC1 also blocks autophagy in response to various environmental cues, such as growth factors, energy status, oxygen, stress, and especially amino acids. One of the key regulators of mTORC1 is the heterotrimeric protein complex TSC (Tuberous Sclerosis Complex). The TSC1 and TSC2 proteins bind to the TBC1D7 component and form the functional TSC complex, which is also the major suppressor of the mTORC1-complex activities. Mutations in the TSC1 and/or TSC2 genes are responsible for the onset of Tuberous Sclerosis in humans. Tuberous Sclerosis is an autosomal dominant genetic disorder characterized by the presence of benign tumors in multiple organ systems. It is remarkable that mutations in the TSC1 and TSC2 genes are responsible for ~85% of patients, while ~15% of those with diagnosed Tuberous Sclerosis do not have any detectable mutations in either of the two genes. The aim of this PhD Thesis is to develop an innovative biological platform that will reliably and efficiently reproduce Tuberous Sclerosis, using as animal model Drosophila melanogaster. D. melanogaster represents one of the most powerful model organisms, and due to its unique advantages, it is used worldwide in biological research, by numerous laboratories, as experimental model, to elucidate important issues concerning the molecular mechanisms of development, differentiation, and aging. By using advanced bioinformatics tools and freely available databases, such as "FlyBase" (flybase.org), "Ensembl Genome Browser 91" (ensembl.org), and "BLAST-NCBI-NIH" (ncbi.nlm. nih.gov/BLAST), we identified in silico the homologous genes of TSC1, TSC2 and TBC1D7 in Drosophila (dTSC1, dTSC2 and dTBC1D7), and achieved silencing of their (post-)transcriptional/translational expression, with the GAL4/UAS genetic tool and RNAi technology, in multiple different tissues. The observed phenotypes of control and genetically targeted flies were evaluated by light (stereo)microscopy and scanning electron microscopy (SEM).Organismal neurological/neuronal/neuromuscular integrity was assessed by examining survival profiles and negative geotaxis patterns in both control and genetically targeted flies, during aging. Flies with reduced dTSC1 and dTSC2 protein expression, specifically in the nervous system, being characterized by strong pathologies, were further selected for brain micro-anatomy and whole-cell protein isolation. Western blotting was performed for examination of possible activation, through phosphorylation, of dTOR downstream effectors, such as the dS6K1 and d4EBP1 target proteins. Most importantly, control fly populations and transgenic flies typified by RNAi-mediated targeting of the dTSC1 or dTSC2 gene, specifically in neuronal tissues, were thoroughly mapped (and quantified) for their proteome (via advanced nano-LC-MS/MS technology), transcriptome (via state-of-the-art RNA-Seq. technology) and metabolome (via new generation LC-MS/MS technology) contents, and they were also subjected to large-scale profiling of their active kinome components, through the novel and innovative PamGene technology application. Gut bacteria are tightly associated with various functions and specific diseases, and the microbiome can influence host physiology and metabolism. Therefore, bacterial DNA was isolated from (mid-)gut tissues of dTSC1 or dTSC2 downregulated flies [specifically in the (mid-)gut], and microbiome analysis was performed, compared to control crosses. Interestingly, mTOR inhibitors and autophagy (suppressed by activated mTORC1) inducers were suitably administered to TSC-targeted flies carrying the strongest pathogenic phenotypes, to reverse brain pathology and to develop a new chemotherapeutic in vivo platform for Tuberous Sclerosis management and treatment in the clinic. Downregulation of the dTSC1 or dTSC2 gene specifically in Drosophila’s eye, resulted in altered morphology from a young age (10 days), with progressive loss of cilia, during senescence. On the other hand, downregulation of the dTBC1D7 protein in fly’s eye did not cause any pathological phenotype. Wing structure and architectural organization was strongly altered in dTSC1- or dTSC2-downregulated flies, with the observed phenotypes varying. Downregulation of the dTBC1D7 protein did not affect wing’s morphology, however was observed an increased on the average wing surface area in dTBC1D7-targeted male flies, compared to control ones. Longevities of both dTSC1-targeted female and male flies were remarkably reduced compared to control conditions, in all examined organ systems (nervous system, giant neuron system, cholinergic/dopaminergic/glutaminergic/serotonergic/γ-amino- butyric neurons, interneuron, motor neurons, muscle, gut) except glial cells, whereas there weren’t notable changes. dTSC1 downregulation affected Drosophila’s climbing capacity, which was reduced, in both sexes, (dopaminergic and γ-aminobutyric neurons are excluded), and the strongest and most pathological phenotype was observed after downregulation of dTSC1 gene in the neuronal system and in the giant fiber system, a fact that was also confirmed through electrophysiology. Exogenous administration of the dTOR kinase inhibitor, Ridaforolimus, to dTSC1-targeted flies especially in the nervous system, caused a significant improvement in female flies’ life expectancy. Downregulation of the dTSC2 gene resulted in altered viability and climbing ability, in a sex- and tissue-dependent manner. Survival of female flies was statistically significant reduced following dTSC2 gene silencing in the nervous system, giant neuron system, cholinergic/dopaminergic/glutamanergic and γ-aminobutyric neurons, interneuron, motor neurons, and gut tissue. Viability of dTSC2-gene targeted male flies in cholinergic/dopaminergic/glutamanergic, γ-aminobutyric neurons as well as in glial cells was impaired, compared to control conditions. Female transgene flies showed motor dysfunction after downregulation of the dTSC2 protein in the nervous system, in giant neuron system, in glutamatergic and motor neurons as well as in glial cells. Climbing ability appeared reduced in most of the examined tissues of dTSC2-targeted male flies. The administration of the dTOR kinase inhibitors, Ridaforolimus and Everolimus, as well as the autophagy inducer Spemidine, to insects with downregulation of the dTSC2 gene in the nervous system, due to the strong motor difficulty they displayed, caused a significant increase in the locomotor performance of male flies, compared to backgrounds without the chemical elements. Mapping of the metabolome, proteome and active kinome in fly populations with dTSC1 or dTSC2 gene silencing in the nervous system, revealed a series of novel biomarkers. Investigating the activation of kinases in Drosophila’s dTSC1 or dTSC2 downregulated brains, exposed a significant increase in the activity of various kinases, including substrates of the dTORC1 complex, such as dp70S6K. In terms of metabolomic analysis, dTSC1 gene silencing, which leads to dysregulation of the dTOR signaling network, resulted in a significant increase in the metabolite betaine, a sugar involved in methionine metabolism, while dTSC2 gene silencing led to an increase of the disaccharide trehalose. Transcriptome analysis of transgenic flies with neuronal downregulated dTSC1 gene expression, showed the transcriptional activation of genes related to D. melanogaster’s immune system activity. Finally, analysis of the microbiome in both dTSC1 and dTSC2 gene silencing flies in midgut tissues, uncovered meaningful differences in microbial cargo between transgenic and control populations. The results obtained by dTBC1D7 protein downregulation show that the absence of this protein has the opposite effect compared to dTSC1 or dTSC2 protein loss. Specifically, the lifespan profiles of female transgenic flies in the nervous system, glutamatergic and motor neurons, muscles and intestine, were significantly improved compared to healthy backgrounds, while in male populations there was an increased life expectancy in all tissues studied, except the nervous system. The kinetic capacity of dTBC1D7-targeted female flies did not show significant alterations compared to control conditions, while in males was observed a tendency to decreased locomotor activity in cholinergic, serotonergic and motor neurons, in glial cells, muscles and midgut tissues. Finally, was investigated the role of SAMTOR protein, a protein that indirectly signals methionine levels to the mTORC1 complex. Strong dSAMTOR protein downregulation in different organ systems (whole body, nervous system, motor neurons, muscle, glial cells) resulted in non-viable phenotypes, while strong dSAMTOR gene silencing in eyes and wings caused severe loss of cilia and dysmorphic wings, respectively. Survival rates of strong dSAMTOR RNAi-mediated flies of both sexes, were significantly reduced, compared to control flies. Moderate levels of downregulation of the dSAMTOR gene did not affect the external morphology of either wings or eyes. Survival profiles affected in a tissue- and sex-dependent manner, while climbing capacity was reduced only upon moderate dSAMTOR silencing in motoneurons. Methionine and betaine treatment of dSAMTOR mildly targeted flies, specifically in neuronal tissues, resulted in reduced viability.For the first time, to the best of our knowledge, we herein prove the: •Successful modeling of human Tuberous Sclerosis in an invertebrate model organism, the Drosophila •Critical contribution, with an autonomous and self-powered manner, of fly’s multiple organic systems, to the acquired pathology of TSC gene-specific and age-dependent compromise in lifespan and neuromuscular integrity •Differential involvement of dTSC1 and dTSC2 genes in the Tuberous Sclerosis pathology observed in TSC-targeted fly environments •Capacity of dTSC1 and dTSC2 proteins to signal in an opposite fashion and pattern compared to the TBC1D7 component, regarding their functionality against dTOR kinase activities, both in systemic and tissue-specific settings •Mechanistic value of multiple transcriptomic, proteomic, metabolomic and kinomic biomarkers, for the identification of TSC-modelled pathology, with emphasis in those controlling immune responses and carbohydrate metabolism pathways •Major role of (mid-)gut microbiome re-programming, as a critical response to (d)TORC1-complex dysregulation, and the development of modelled Tuberous Sclerosis pathology, in TSC-targeted in vivo environments, during Drosophila aging •Ability of the in vivo development of novel and powerful chemotherapeutic schemes, derived from the modelled disease, with the prospect and promise of their safe and successful administration in the clinical practice, for the Tuberous Sclerosis-suffering patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Katarachia, Stamatia
  • Καταραχιά, Σταματία

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55246

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Katarachia, Stamatia; Καταραχιά, Σταματία. Ανάπτυξη ζωικών προτύπων ανθρώπινων ασθενειών μέσω ιστο-ειδικής μειορρύθμισης γονιδίων ελέγχου ενδοκυτταρικών σηματοδοτικών δικτύων στο δίπτερο έντομο Drosophila melanogaster. National and Kapodistrian University of Athens, 2023. http://hdl.handle.net/10442/hedi/55246